AQR Capital Management’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.72M | Sell |
64,728
-80,391
| -55% | -$2.13M | ﹤0.01% | 1877 |
|
|
2025
Q1 | $3.44M | Sell |
145,119
-392,120
| -73% | -$9.29M | ﹤0.01% | 1318 |
|
|
2024
Q4 | $21.5M | Buy |
537,239
+73,710
| +16% | +$2.95M | 0.03% | 613 |
|
|
2024
Q3 | $29.1M | Buy |
463,529
+395,459
| +581% | +$24.8M | 0.04% | 525 |
|
|
2024
Q2 | $3.61M | Buy |
68,070
+28,180
| +71% | +$1.49M | 0.01% | 1177 |
|
|
2024
Q1 | $3.27M | Sell |
39,890
-7,569
| -16% | -$621K | 0.01% | 1187 |
|
|
2023
Q4 | $883K | Sell |
47,459
-8,204
| -15% | -$153K | ﹤0.01% | 1648 |
|
|
2023
Q3 | $616K | Buy |
55,663
+24,266
| +77% | +$269K | ﹤0.01% | 1776 |
|
|
2023
Q2 | $509K | Buy |
+31,397
| New | +$509K | ﹤0.01% | 1782 |
|
|
2022
Q3 | – | Sell |
-122,356
| Closed | -$354K | – | 2330 |
|
|
2022
Q2 | $354K | Buy |
122,356
+78,431
| +179% | +$227K | ﹤0.01% | 1803 |
|
|
2022
Q1 | $132K | Buy |
+43,925
| New | +$132K | ﹤0.01% | 2118 |
|
|
2019
Q3 | – | Sell |
-33,106
| Closed | -$275K | – | 2165 |
|
|
2019
Q2 | $275K | Buy |
33,106
+206
| +0.6% | +$1.71K | ﹤0.01% | 1897 |
|
|
2019
Q1 | $327K | Sell |
32,900
-1,256
| -4% | -$12.5K | ﹤0.01% | 1939 |
|
|
2018
Q4 | $261K | Sell |
34,156
-26,778
| -44% | -$205K | ﹤0.01% | 2004 |
|
|
2018
Q3 | $1.06M | Sell |
60,934
-18,542
| -23% | -$323K | ﹤0.01% | 1682 |
|
|
2018
Q2 | $754K | Buy |
+79,476
| New | +$754K | ﹤0.01% | 1833 |
|